Tuberculosis
Conditions
Keywords
TB, HIV, Test and Treat, Linkage
Brief summary
The purpose of this study is (1) to establish the feasibility, yield, and clinical impact of a Test & Treat TB strategy on a mobile HIV screening unit in South Africa and (2) to assess the cost and cost-effectiveness of this mobile, integrated HIV/TB screening strategy for maximizing linkage to TB care and treatment completion.
Interventions
Sponsors
Study design
Eligibility
Inclusion criteria
* English or Zulu speaking * presenting for screening at mobile unit * voluntarily undergoing HIV testing * able and willing to give informed consent * willing to share HIV and TB test results * willing to attend one of six local clinics for treatment * access to a mobile phone
Exclusion criteria
* pregnant
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of patients who complete tuberculosis treatment | 6 months |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Proportion of eligible participants able to produce sputum samples | 20 months | — |
| Prevalence of TB among those tested | 20 months | — |
| Prevalence of tuberculosis and rifampin resistance | 20 months | The GeneXpert test can detect rifampin resistant strains of tuberculosis |
| Proportion of mobile testers screened for tuberculosis | 20 months | — |
| Proportion returning to the mobile tester for TB test result | 20 months | — |
| Linkage to TB care (first visit to a local TB treatment site ascertained from clinic record) | 1 month | — |
| ART initiation date as documented by clinic record for those HIV co-infected | 6 months | — |
| Distribution of TB symptoms ascertained from TB symptom screen questionnaire | 20 months | — |
Countries
South Africa